Iragavarapu C - Search Results

1

Performance status, comorbidities, and cycles of methotrexate exert the greatest influence on outcomes of primary and secondary CNS lymphomas: the Lexington experience.

Curry LD, Munker R, Li N, Yan D, Pryor P, Nozad S, Keller P, Monohan GP, Iragavarapu C, Krem MM. Curry LD, et al. Among authors: iragavarapu c. Ann Hematol. 2023 Jan;102(1):141-154. doi: 10.1007/s00277-022-05018-z. Epub 2022 Nov 11. Ann Hematol. 2023. PMID: 36367559 Review.

2

[No title available]

[No authors listed] [No authors listed] PMID: 38580225

3

Acquired von Willebrand syndrome in a patient with monoclonal gammopathy of unknown significance: A case report.

Gupta G, Veedu JS, Chahine Z, Iragavarapu C. Gupta G, et al. Among authors: iragavarapu c. Clin Case Rep. 2024 Feb 2;12(2):e8361. doi: 10.1002/ccr3.8361. eCollection 2024 Feb. Clin Case Rep. 2024. PMID: 38314184 Free PMC article.

4

Unveiling the Genetic and Clinical Differences of Acute Myeloid Leukemia (AML) in Obese Patients.

Yalniz FF, Johnson A, Alnimer Y, Chahine Z, Morris T, Yadav R, Taj H, Iragavarapu C, Munker R, Monohan G, Wai S, Zhang S, Nozad S, Qasrawi A. Yalniz FF, et al. Among authors: iragavarapu c. Eur J Haematol. 2024 Nov 13. doi: 10.1111/ejh.14338. Online ahead of print. Eur J Haematol. 2024. PMID: 39535461

5

Multimodality Imaging Guided Diagnosis and Treatment Response Evaluation in a Patient with Lymphoma with Right Atrioventricular Involvement.

Chen J, Ahmed T, Ahmed T, Iragavarapu C, Ramlal R, Arbune A. Chen J, et al. Among authors: iragavarapu c. Curr Probl Cardiol. 2022 Sep;47(9):101273. doi: 10.1016/j.cpcardiol.2022.101273. Epub 2022 Jun 2. Curr Probl Cardiol. 2022. PMID: 35661810 Review.

6

Myocarditis Concurrent with Sweet Syndrome: A Presentation of Acute Myeloid Leukemia.

Burkeen CG, Pottinger D, Iragavarapu C, Ramlal R, Hildebrandt G. Burkeen CG, et al. Among authors: iragavarapu c. Case Rep Hematol. 2021 May 11;2021:6621007. doi: 10.1155/2021/6621007. eCollection 2021. Case Rep Hematol. 2021. PMID: 34055428 Free PMC article.

7

Lisocabtagene Maraleucel for the treatment of B-cell lymphoma.

Iragavarapu C, Hildebrandt G. Iragavarapu C, et al. Expert Opin Biol Ther. 2021 Sep;21(9):1151-1156. doi: 10.1080/14712598.2021.1933939. Epub 2021 Jun 28. Expert Opin Biol Ther. 2021. PMID: 34030548 Review.

8

SRSF2 mutations in myelodysplasia/myeloproliferative neoplasms.

Aujla A, Linder K, Iragavarapu C, Karass M, Liu D. Aujla A, et al. Among authors: iragavarapu c. Biomark Res. 2018 Sep 26;6:29. doi: 10.1186/s40364-018-0142-y. eCollection 2018. Biomark Res. 2018. PMID: 30275952 Free PMC article. Review.

9

SETBP1 mutations as a biomarker for myelodysplasia /myeloproliferative neoplasm overlap syndrome.

Linder K, Iragavarapu C, Liu D. Linder K, et al. Among authors: iragavarapu c. Biomark Res. 2017 Dec 6;5:33. doi: 10.1186/s40364-017-0113-8. eCollection 2017. Biomark Res. 2017. PMID: 29225884 Free PMC article. Review.

10

ABT-199 (venetoclax) and BCL-2 inhibitors in clinical development.

Cang S, Iragavarapu C, Savooji J, Song Y, Liu D. Cang S, et al. Among authors: iragavarapu c. J Hematol Oncol. 2015 Nov 20;8:129. doi: 10.1186/s13045-015-0224-3. J Hematol Oncol. 2015. PMID: 26589495 Free PMC article. Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

13 results

Search Page

Filters